Nebenwirkungen · Xelevia
Xelevia 25 mg film-coated tablets Xelevia 50 mg film-coated tablets Xelevia 100 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-117569 · Präparat HOS-094641
Description of selected adverse reactions In addition to the drug-related adverse experiences described above, adverse experiences reported regardless of causal relationship to medication and occurring in at least 5 % and more commonly in patients treated with sitagliptin included upper respiratory tract infection and nasopharyngitis. Additional adverse experiences reported regardless of causal relationship to medication that occurred more frequently in patients treated with sitagliptin (not reaching the 5 % level, but occurring with an incidence of > 0.5 % higher with sitagliptin than that in the control group) included osteoarthritis and pain in extremity.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-01T17:33:00Z · SHA-256 f08aea892d6a7b9cf75b34f4b4074c9f6b71db0d601e841798224bb137a5083a · Passage 88fe0573d878d8648b7b7bd8351c898a995aa8967f1776f34e700876e755c9ea · Zeichen 3876–4542 im Abschnitt